Citation Impact
Citing Papers
2012
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo
2006
Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54
2003 Standout
Guidelines for Acromegaly Management: An Update
2009
OPTIMAL IODINE NUTRITION DURING PREGNANCY, LACTATION AND THE NEONATAL PERIOD
2004
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Rapid and sustained reduction of serum growth hormone and insulin-like growth factor-1 in patients with acromegaly receiving lanreotide Autogel® therapy: a randomized, placebo-controlled, multicenter study with a 52 week open extension
2009
Clinical efficacy and safety results for dose escalation of somatostatin receptor ligands in patients with acromegaly: a literature review
2010
Iodine supplementation of pregnant women in Europe: a review and recommendations
2004
Longitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
2001 Standout
Circulating Iodide Concentrations during and after Pregnancy1
1998
Acromegaly
2006 Standout
Repeat endoscopic transsphenoidal surgery for acromegaly: remission and complications
2013
The Antitumoral Effects of Somatostatin Analog Therapy in Acromegaly
2005
The management of advanced thyroid cancer
2004
What Happens to the Normal Thyroid During Pregnancy?
1999
The desmopressin test as a predictive factor of outcome after pituitary surgery for Cushing's disease
2004
Home administration of lanreotide Autogel® by patients with acromegaly, or their partners, is safe and effective
2007
Thyroid cancer
2016 Standout
Acromegaly and Pregnancy: A Retrospective Multicenter Study of 59 Pregnancies in 46 Women
2010
Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules
1995
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
New reference values for thyroid volume by ultrasound in iodine-sufficient schoolchildren: a World Health Organization/Nutrition for Health and Development Iodine Deficiency Study Group Report
2004
The regulation of thyroid function during normal pregnancy: importance of the iodine nutrition status
2004
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer
2011
Effectiveness of self- or partner-administration of an extended-release aqueous-gel formulation of lanreotide in lanreotide-naïve patients with acromegaly
2009
Review article: somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumours
2009
Somatostatin Receptor-Specific Analogs: Effects on Cell Proliferation and Growth Hormone Secretion in Human Somatotroph Tumors1
2001
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
2013 Standout
Using supramolecular hydrogels to discover the interactions between proteins and molecular nanofibers of small molecules
2012
Cushing's syndrome
2015 Standout
The role of 18F-FDG PET/CT in detecting metastatic deposits of recurrent medullary thyroid carcinoma: A prospective study
2007
Acromegaly pathogenesis and treatment
2009
Two Common Naturally Occurring Mutations in the Human Gonadotropin-Releasing Hormone (GnRH) Receptor Have Differential Effects on Gonadotropin Gene Expression and on GnRH-Mediated Signal Transduction
2003
Biodegradable luminescent porous silicon nanoparticles for in vivo applications
2009 Standout
The Potential Repercussions of Maternal, Fetal, and Neonatal Hypothyroxinemia on the Progeny
2000
Cushing’s syndrome in medullary thyroid carcinoma
1995
The GPR54 Gene as a Regulator of Puberty
2003 Standout
Thyroid Disorders Associated with Pregnancy
2005
A Single-Dose Comparison of the Acute Effects between the New Somatostatin Analog SOM230 and Octreotide in Acromegalic Patients
2004
Management of hereditary medullary thyroid carcinoma
2016
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
2011 Standout
Maternal and child undernutrition and overweight in low-income and middle-income countries
2013 Standout
Nanocarriers as an emerging platform for cancer therapy
2007 Standout
Primary medical therapy for acromegaly
2003
Impact evaluation of efforts to eliminate iodine deficiency disorders in Nigeria
2003
Pregnancy and Iodine
2001
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Insulin and insulin-like growth factor signalling in neoplasia
2008 Standout
Treatment of advanced medullary thyroid cancer with an alternating combination of 5 FU-streptozocin and 5 FU-dacarbazine
1995
Therapeutic potential of β-arrestin- and G protein-biased agonists
2010 StandoutNobel
The Timing of Total Thyroidectomy in RET Gene Mutation Carriers Could Be Personalized and Safely Planned on the Basis of Serum Calcitonin: 18 Years Experience at One Single Center
2011
Prevalence, Phenotypic Spectrum, and Modes of Inheritance of Gonadotropin-Releasing Hormone Receptor Mutations in Idiopathic Hypogonadotropic Hypogonadism1
2001
Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline
2011 Standout
Assessment of iodine nutrition in populations: past, present, and future
2012
Maternal and child undernutrition: global and regional exposures and health consequences
2008 Standout
Obesity, haemostasis and the fibrinolytic system
2002
Pituitary Disorders During Pregnancy
2006
Acromegaly: An Endocrine Society Clinical Practice Guideline
2014 Standout
Long-Acting Somatostatin Analog Therapy of Acromegaly: A Meta-Analysis
2005
Use of the Thyroid Hormone Analogue Eprotirome in Statin-Treated Dyslipidemia
2010
Monogenic Disorders of Puberty
2002
Genetic Causes of Human Reproductive Disease
2002
Clinical, quality of life, and economic value of acromegaly disease control
2011
Treatment of medullary thyroid carcinoma: an update.
2001
Postoperative Complications After Prophylactic Thyroidectomy for Very Young Patients With Multiple Endocrine Neoplasia Type 2
2015
Apoptosis
2002 Standout
Effectiveness of retinoic acid treatment for redifferentiation of thyroid cancer in relation to recovery of radioiodine uptake
2009
Ultrasonographic evidence of joint thickening reversibility in acromegalic patients treated with lanreotide for 12 months
1999
Growth-hormone and prolactin excess
1998
Effects of octreotide exposure during pregnancy in acromegaly
2009
Consensus Statement on Management of Intersex Disorders
2006 Standout
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
What works? Interventions for maternal and child undernutrition and survival
2008 Standout
Efficacy of oral iodized peanut oil is greater than that of iodized poppy seed oil among Indonesian schoolchildren
2006
Management of medullary thyroid carcinoma and MEN2 syndromes in childhood
2011
Iodine-deficiency disorders
2008 Standout
Exercise-induced microalbuminuria in patients with active acromegaly: Acute effects of slow-release lanreotide, a long-acting somatostatin analog
2000
Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer
2007
Medullary thyroid carcinoma
2004
Cushing's syndrome
2006 Standout
Growth hormone and the heart
2001
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Adipose Tissue as an Endocrine Organ
2004 Standout
Guidelines for Acromegaly Management
2002
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer
2012
The Prognostic Significance of Nodal Metastases from Papillary Thyroid Carcinoma Can Be Stratified Based on the Size and Number of Metastatic Lymph Nodes, as Well as the Presence of Extranodal Extension
2012
Iodine Nutrition Improves in Latin America
2004
Long-Term Environmental Exposure to Perchlorate Through Drinking Water and Thyroid Function During Pregnancy and the Neonatal Period
2005
Impact of Nanotechnology on Drug Delivery
2009 Standout
Assessing Iodine Status and Monitoring Progress of Iodized Salt Programs
2004
A Critical Analysis of Clinically Available Somatostatin Analog Formulations for Therapy of Acromegaly
2008
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Is basal ultrasensitive measurement of calcitonin capable of substituting for the pentagastrin‐stimulation test?
2012
Growth Hormone Receptor Antagonists: Discovery, Development, and Use in Patients with Acromegaly
2002
Therapeutic Nanoparticles for Drug Delivery in Cancer
2008 Standout
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
2015 Standout
Octreotide-Targeted Liposomes Loaded with CPT-11 Enhanced Cytotoxicity for the Treatment of Medullary Thyroid Carcinoma
2010
In vivo somatostatin receptor imaging in medullary thyroid carcinoma.
1993
Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline
2008
Optimizing Control of Acromegaly: Integrating a Growth Hormone Receptor Antagonist into the Treatment Algorithm
2003
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
2004 Standout
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Cabergoline in the Treatment of Acromegaly: A Study in 64 Patients
1998
Chemoembolization for Liver Metastases from Medullary Thyroid Carcinoma
2006
Medullary thyroid cancer diagnosis: An appraisal
2013
Assessing iodine status and monitoring progress of iodized salt programs.
2004
The Diagnosis and Medical Management of Advanced Neuroendocrine Tumors
2004
Genetic Causes of Human Reproductive Disease
2002
Functional π-Gelators and Their Applications
2014 Standout
Thyroid Hormone Regulation of Metabolism
2014 Standout
Are Australian children iodine deficient? Results of the Australian National Iodine Nutrition Study
2006
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
The association of hypotestosteronemia with coronary artery disease in men.
1994
Multistage nanoparticle delivery system for deep penetration into tumor tissue
2011 StandoutNobel
Cancer treatment and survivorship statistics, 2019
2019 Standout
The Role of Radiation Therapy in the Treatment of Medullary Thyroid Cancer
2010
Thyroid ultrasound compared with World Health Organization 1960 and 1994 palpation criteria for determination of goiter prevalence in regions of mild and severe iodine deficiency
2000
Lanreotide 60 mg, a New Long-Acting Formulation: Effectiveness in the Chronic Treatment of Acromegaly
2003
Demonstration of Enhanced Potency of a Chimeric Somatostatin-Dopamine Molecule, BIM-23A387, in Suppressing Growth Hormone and Prolactin Secretion from Human Pituitary Somatotroph Adenoma Cells
2002
Internalization of sst2, sst3, and sst5 receptors: effects of somatostatin agonists and antagonists.
2006
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society
2013 Standout
In vivo cytotoxicity of ovarian cancer cells through tumor-selective expression of the BAX gene.
1999
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Guidelines for the management of thyroid cancer
2014 Standout
Islet Hyperplasia in Adults: Challenge to Preoperatively Diagnose Non‐Insulinoma Pancreatogenic Hypoglycemia Syndrome
2006
Management of Thyroid Dysfunction during Pregnancy and Postpartum: An Endocrine Society Clinical Practice Guideline
2012 Standout
Effects of the Thyromimetic Agent Diiodothyropropionic Acid on Body Weight, Body Mass Index, and Serum Lipoproteins: A Pilot Prospective, Randomized, Controlled Study
2010
Improvement of Endothelial Dysfunction in Acromegaly after Transsphenoidal Surgery
2008
Thyroid carcinoma
2003 Standout
Pituitary Magnetic Resonance Imaging Findings Do Not Influence Surgical Outcome in Adrenocorticotropin-Secreting Microadenomas
2004
Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy
2003
Works of P. Caron being referenced
Prognostic Factors of Disease-Free Survival after Thyroidectomy in 170 Young Patients with a RET Germline Mutation: A Multicenter Study of the Groupe Français d'Etude des Tumeurs Endocrines
2010
Insulin, C-peptide and proinsulin for the biochemical diagnosis of hypoglycaemia related to endogenous hyperinsulinism
2007
Insulin levels measured with an insulin-specific assay in patients with fasting hypoglycaemia related to endogenous hyperinsulinism
2003
EFFECTS OF HYPERTHYROIDISM ON BINDING PROTEINS FOR STEROID HORMONES
1989
Variable growth hormone profiles following withdrawal of long-term 30mg slow-release lanreotide treatment in acromegalic patients: clinical implications
2000
Urinary Iodine Excretion During Normal Pregnancy in Healthy Women Living in the Southwest of France: Correlation with Maternal Thyroid Parameters
1997
Acromegalic Cardiomyopathy: A Review of the Literature
2003
One‐year follow‐up of patients with acromegaly treated with fixed or titrated doses of lanreotide Autogel®
2004
Expression of the cell death-inducing gene bax in carcinomas developed from the follicular cells of the thyroid gland.
1996
Plasminogen activator inhibitor in plasma is related to testosterone in men
1989
Thyroid volume and urinary iodine in European schoolchildren: standardization of values for assessment of iodine deficiency
1997
Recent advances in treatment of medullary thyroid carcinoma
2007
Lymph node management in clinically node-negative patients with papillary thyroid carcinoma
2010
Defective Efficacy of Retinoic Acid Treatment in Patients with Metastatic Thyroid Carcinoma
2006
Successful pregnancy in an infertile woman with a thyrotropin-secreting macroadenoma treated with somatostatin analog (octreotide)
1996
Efficacy of the New Long-Acting Formulation of Lanreotide (Lanreotide Autogel) in the Management of Acromegaly
2002
Le carcinome médullaire de la thyroïde : les nouvelles approches thérapeutiques
2007
Resistance of Hypogonadic Patients with Mutated GnRH Receptor Genes to Pulsatile GnRH Administration
1999
BIM-23244, a Somatostatin Receptor Subtype 2- and 5-Selective Analog with Enhanced Efficacy in Suppressing Growth Hormone (GH) from Octreotide-Resistant Human GH-Secreting Adenomas1
2001
Efficacy of the New Long-Acting Formulation of Lanreotide (Lanreotide Autogel) in the Management of Acromegaly
2002
Three Year Follow-Up of Acromegalic Patients Treated with Intramuscular Slow-Release Lanreotide
1997
Successful pregnancy in an infertile woman with a thyrotropin-secreting macroadenoma treated with somatostatin analog (octreotide).
1996
Markers of tumor invasion are major predictive factors for the long-term outcome of corticotroph microadenomas treated by transsphenoidal adenomectomy
2000
Results of long‐term continuous subcutaneous octreotide administration in 14 patients with medullary thyroid carcinoma
1992
[Somatuline(R) Autogel(R), a new formulation of lanreotide for the treatment of acromegalic patients].
2002